Limiting saturated fat intake can decrease a person’s risk of adverse cardiovascular events by a significant margin, according to a new systematic review of 15 different studies.

Treating atrial fibrillation (AF) patients with catheter ablation is associated with a decreased risk of mortality, heart failure admission and stroke, according to new findings published in the Journal of the American Heart Association.

Hospitals throughout the United States have reported that a general fear of COVID-19 has led to significant drops in patients presenting with heart attack symptoms and other cardiovascular issues.

Ticagrelor has been approved by the FDA for reducing the risk of a first heart attack or stroke in high-risk coronary artery disease (CAD) patients.

The use of hydroxychloroquine and chloroquine as potential COVID-19 treatments has been one of the pandemic’s biggest stories, with some studies revealing promise and others offering reasons for concern.

Non-vitamin K antagonist oral anticoagulants are a valuable treatment option for atrial fibrillation patients with a prior intracranial hemorrhage, according to new findings published in JAMA Network Open. 

The emergency use authorization covers patients who experience right-sided heart failure following left ventricular assist device implantation, myocardial infarction, heart transplant or open-heart surgery.

The study's authors emphasized the importance of interventions such as patient communication and education.